InstaMed
Noah Dermer from InstaMed and Tim Winston from Coalfire discuss how P2PE works and how your organization can benefit from leveraging a PCI-validated P2PE v2.0 solution. Learn more about InstaMed's PCI P2PE v2.0 validation.
Watch Now
Cancerresearch
Small cell lung cancer (SCLC) is aggressive and often difficult to treat, but many patients may have new hope. On August 17, 2018, the FDA approved the first immunotherapy the checkpoint inhibitor nivolumab (Opdivo, Bristol-Myers Squibb for patients with small cell lung cancer. Since this approval, there has been renewed focus on how to make different immunotherapies work for a disease which typicallly comprises 10-15% of all lung cancer cases. In this webinar for patients and caregivers, Matthew Hellmann, M.D., of Memorial Sloan Kettering Cancer Center discusses the new FDA approval, clinical trials, and potential treatments for patients with small cell lung cancer.
Watch Now
Ihealthtran
Due to the complexity of the disease biology, rapidly increasing treatment options, patient mobility, multi-disciplinary care teams, and high costs of treatment - informatics can play a more substantial role in improving outcomes and reducing the cost of cancer care. In this webinar, we will review how tumor board solutions, precision medicine frameworks, and oncology pathways are being used within clinical quality programs as well as understanding their role in driving operational improvements and increasing patient retention. We will demonstrate the requirements around both interoperability and the clinical depth needed to ensure adoption and effective capture and use of information to accomplish these goals.
Watch Now
TOC,Conductivity, and Microbial detection are all required measurements in regulated pharmaceutical waters. Today, all of these parameters can be continuously measured directly from these waters.
Watch Now